urinary%20tract%20infection%20(pediatric)
URINARY TRACT INFECTION (PEDIATRIC)
Nonspecific urinary tract infection symptoms in infants <3 months are fever, feeding difficulties, vomiting, lethargy, irritability and failure to thrive.
Toddlers and preschoolers have unusual odor of urine, abdominal or flank pain, frequency, dysuria, and urgency.
School-age children have the classical symptoms of fever, frequency, urgency and dysuria.
Consider UTI in all seriously ill children even when there is evidence of infection outside the urinary tract.
Drug Information

Indication: Short-term treatment of upper & lower resp tract, skin & soft tissue, GUT infections. Tab & inj Sh...

Indication: Infections of the resp tract, middle ear (otitis media), paranasal sinuses (sinusitis) especially caused by gm...

Indication: Upper & lower resp tract infection, upper & lower UTI, peritonitis, cholecystitis, cholangitis & o...

Indication: Lower resp tract, complicated & uncomplicated UTI, intra-abdominal, skin & skin structure infections; ...

Indication: Upper & lower resp tract infections including sinusitis, otitis media & epiglottitis, bacterial pneumo...

Indication: Upper & lower resp tract infections, GUT, skin & soft tissue infections, gonorrhoea, acute uncomplicat...

Indication: Upper & lower resp tract, GUT, skin & soft tissue infections, gonorrhoea, acute uncomplicated gonococc...

Indication: Infections due to gm -ve & +ve organisms & non-penicillinase-producing staph.

Indication: Upper & lower resp tract infections eg, sinusitis, otitis media, epiglottitis; bacterial pneumonia; UTI, p...

Indication: Resp tract, ENT, urinary tract, soft-tissue, bone & joint, O&G infections; pelvic inflammatory disease...

1  /  16
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
22 Mar 2017
Both the American Thyroid Association (ATA) paediatric risk classification and dynamic risk stratification (DRS) based on the response to initial therapy appear to be useful in predicting recurrent or persistent disease in paediatric patients with differentiated thyroid cancer (DTC), suggest a recent study.
Roshini Claire Anthony, 27 Jun 2019

A 2-week course of the immunotherapy drug teplizumab delayed the onset of type 1 diabetes (T1D) in individuals at high risk for the condition, according to a phase II trial conducted by the TrialNet Study Group and presented at ADA 2019.